Western Wealth Management »

SPDR S&P Pharmaceuticals shares owned by Western Wealth Management

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Western Wealth Management from 13F filings

Historical chart of Western Wealth Management investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Western Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Western Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $34k 636 54.08

More positions owned by Western Wealth Management

Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPYM)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
Spdr Series Trust State Street Spd (SPYG)
First Tr Exchange Traded Smid Risng Etf (SDVY)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom (AVGO)

View all positions for Western Wealth Management

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
Wells Fargo & Company
Kingsview Wealth Management
Morgan Stanley
Envestnet Asset Management
First Citizens Bank & Trust
Envestnet Portfolio Solutions
LPL Financial
Susquehanna International
Branch Banking & Trust Company
Cetera Investment Advisers
Private Advisor
Clark Capital Management Group
Two Sigma Investments
Citigroup

View all funds holding SPDR S&P Pharmaceuticals